Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, Kita Y, et al. Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular Disease: An Individual Participant Data Meta-Analysis. Hypertension. 2017;69:1045–52.
Article CAS PubMed Google Scholar
Sang T, Lv N, Dang A, Cheng N, Zhang W. Brachial-ankle pulse wave velocity and prognosis in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Hypertension Res. 2021;44:1175–85.
Ohkuma T, Tomiyama H, Ninomiya T, Kario K, Hoshide S, Kita Y, et al. Proposed Cutoff Value of Brachial-Ankle Pulse Wave Velocity for the Management of Hypertension. Circ J 2017;81:1540–2.
Cicero AF, Salvi P, D’Addato S, Rosticci M, Borghi C, Brisighella Heart Study g. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens. 2014;32:57–64.
Article CAS PubMed Google Scholar
Mule G, Riccobene R, Castiglia A, D’Ignoto F, Ajello E, Geraci G, et al. Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients. Nutr Metab Cardiovasc Dis. 2014;24:744–50.
Article CAS PubMed Google Scholar
Chu C, Dai Y, Mu J, Yang R, Wang M, Yang J, et al. Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort. J Hypertens. 2017;35:S10–S15.
Article CAS PubMed Google Scholar
Ramirez AJ, Christen AI, Sanchez RA. Serum Uric Acid Elevation is Associated to Arterial Stiffness in Hypertensive Patients with Metabolic Disturbances. Curr Hypertens Rev. 2018;14:154–60.
Article CAS PubMed Google Scholar
Liu J, Wang K, Liu H, Zhao H, Zhao X, Lan Y, et al. Relationship between carotid-femoral pulse wave velocity and uric acid in subjects with hypertension and hyperuricemia. Endocr J. 2019;66:629–36.
Article CAS PubMed Google Scholar
Maloberti A, Rebora P, Andreano A, Vallerio P, De Chiara B, Signorini S, et al. Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid. J Clin Hypertens. 2019;21:975–83.
Kanbay M, Girerd N, Machu JL, Bozec E, Duarte K, Boivin JM, et al. Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up. Am J Hypertens. 2020;33:869–78.
Article CAS PubMed Google Scholar
An LN, Rong N, Ning M, Feng LL, Chen ZH, Liu WQ, et al. High serum uric acid is associated with increased arterial stiffness in hypertension. Aging. 2020;12:14569–81.
Article CAS PubMed PubMed Central Google Scholar
Lina A, Yujing W, Lizhen L, Congliang M, Lina X, Guokun W, et al. High serum uric acid is a risk factor for arterial stiffness in a Chinese hypertensive population: A cohort study. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01591-0.
Motobe K, Tomiyama H, Koji Y, Yambe M, Gulinisa Z, Arai T, et al. Cut-off value of the ankle-brachial pressure index at which the accuracy of brachial-ankle pulse wave velocity measurement is diminished. Circ J. 2005;69:55–60.
Maruhashi T, Hisatome I, Kihara Y, Higashi Y. Hyperuricemia and endothelial function: From molecular background to clinical perspectives. Atherosclerosis. 2018;278:226–31.
Article CAS PubMed Google Scholar
Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;16:3553–62.
Article CAS PubMed Google Scholar
Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol. 2005;25:425–33.
Article CAS PubMed Google Scholar
Shiina K, Tomiyama H, Tanaka A, Yoshida H, Eguchi K, Kario K, et al. Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: a subanalysis of the PRIZE study. Hypertens Res. 2022;45:602–11.
Article CAS PubMed Google Scholar
Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro M, Hongo H, et al. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA). Eur J Med Res. 2023;28:238.
留言 (0)